发明申请
- 专利标题： Crystalline form IV of linezolid
- 专利标题（中）： 利奈唑胺的结晶形式IV
-
申请号： US12229402申请日： 2008-08-22
-
公开(公告)号： US20080319191A1公开(公告)日： 2008-12-25
- 发明人: Judith Aronhime , Tamas Koltai , Viviana Braude , Serguei Fine , Tamar Niddam
- 申请人： Judith Aronhime , Tamas Koltai , Viviana Braude , Serguei Fine , Tamar Niddam
- 专利权人： Teva Pharmaceutical Industries Ltd.,Teva Pharmaceuticals USA, Inc. for Barbados
- 当前专利权人： Teva Pharmaceutical Industries Ltd.,Teva Pharmaceuticals USA, Inc. for Barbados
- 主分类号： C07D413/02
- IPC分类号： C07D413/02
摘要：
The present invention provides a novel crystalline form of linezolid referred to herein as Form IV as well as methods for the preparation and use of Form IV. The present invention provides pharmaceutical compositions that comprise therapeutically effective amounts of Form IV that can be used to treat patients suffering from gram-positive bacterial infections. Various processes for making crystalline linezolid Form IV are disclosed.
信息查询
